🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at age 51 after a personal fight with pancreatic cancer.

“The shining star of our household has faded away for us in this life,” his relatives confirmed. “After a lengthy and courageous battle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, known to his followers around the world as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his innovative modern soul style and collaborations with high-profile artists.

He launched his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The record reached No. 4 on the R&B charts, went platinum later that year, and earned multiple award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that propelled his artistic journey into the stratosphere. The album debuted at the top spot on both the R&B charts and the main album chart. He received two Grammys: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the cultural zeitgeist. The personal depiction showed the artist, famously bare to his midsection, performing straight into the camera.

D’Angelo stepped back from the public eye after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe car crash that left him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with a further No. 1 debut on the R&B chart and a award for Top R&B Record.

Again, in his own mysterious way, D’Angelo had limited public outings in the following years.

The singer was announced as a top act for the 2025 Roots Picnic festival, but his performance was called off, citing an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the weeks before his passing, he had apparently been hospitalized for an extended period and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and hardest to prevent forms of the disease, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only provide cherished moments with his loved ones, but we are forever thankful for the heritage of deeply emotional music he has left us,” his kin said.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic malignancy impacts the pancreas, a small organ that generates the hormone insulin and plays an essential role in digestion, among additional roles. The position and dimensions of the pancreas in the body make it more challenging to identify malignancy.

Although this cancer accounts for only approximately three percent of malignancy cases each year in the United States, it is responsible for 7% of cancer deaths.

Almost seventy thousand individuals will be found to have pancreatic cancer and about 52,000 will die of the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have few and poor therapies, and a smaller window to make a meaningful impact on the well-being of patients,” noted a medical oncologist.

Since pancreatic cancer rarely causes initial signs, it’s often diagnosed only once the condition is advanced. Even when a patient has symptoms they are usually nonspecific and may be mistaken for a several everyday ailments.

“As of yet, there is no good way to identify this malignancy in the early stages, apart from listening to your body and speaking with your doctor if there are new or unusual signs,” said a medical director.

Common symptoms of this disease include:

• abdominal or lower back pain
• reduced body mass
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in individuals in the 65 to 75 range. However, numerous malignancies, including pancreatic cancer, have become more common in younger adults.

“This disease diagnosed before the age of 50 is deemed uncommon, yet concerningly, clinicians are noticing a rising count of younger individuals suffering from this disease,” commented a specialist.

Genetic Background Impacts Disease Probability

In the absence of reliable detection methods for pancreatic cancer, experts emphasized the importance of knowing your family’s cancer history. Some risk factors, such as smoking and excess weight also play a role in the development of this disease.

Black individuals have the highest incidence of this malignancy in the U.S. and are most likely to be found to have inoperable cancer.

“The first step toward lowering one’s chance of pancreatic cancer is assessing personal risk factors. Individuals should examine their genetic background, genetic background, and health issues, such as diabetes, chronic pancreatitis, or obesity that may increase their susceptibility,” advised a medical professional.

Hereditary elements are associated with as much as ten percent of all this malignancy instances. If someone in your household has had this disease, you may want to consider genetic testing.

“For people with a family history of pancreatic cancer or those having elevated risk genetic mutations, screening may involve advanced imaging such as MRI scans or internal ultrasound to detect early changes in the pancreas,” he clarified.

For those wishing to reduce their risk, lifestyle changes may make a difference. The most effective action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Excessive drinking is linked to pancreatitis, a contributing element for this malignancy, so reducing or avoiding drinks may help lower your chance.

Controlling your body mass or losing weight may also aid decrease your susceptibility. People with excess weight are twenty percent more prone to get pancreatic cancer. Pancreatic cancer also occurs more often in people with diabetes, and reducing weight can also lower the chance of type 2 diabetes.

In spite of this disease’s poor prognosis, there is still hope.

“We are making progress with treatments and more recent mixed drug treatments. There are emerging precision medicines that are already showing results,” remarked a specialist.

For many individuals, however, awareness about this uncommon but {dev